Skip to content

 

Search Result

February 27, 2019 | Fact Sheet

A tip sheet providing guidance on how to have conversations with your patients about long acting injectable antipsychotics.

Category: Organized, evidence-based care
Key Audience: All clinicians
Tags: LAIs, LAMs, Long Acting Injectable Medications, Long-Acting Injectables, Long-Acting Medications
February 27, 2019 | Worksheet

Use the included checklist to map out the steps for determining costs, then continue on to assess your patient's coverage for LAI antipsychotics and learn how to get started working with your patient’s particular situation.

Category: Organized, evidence-based care
Key Audience: All clinicians
Tags: LAIs, LAMs, Long Acting Injectable Medications, Long-Acting Injectables, Long-Acting Medications
February 27, 2019 | Fact Sheet

This case study summarizes the experiences of A.W., a 25-year-old male who experienced the onset of schizophrenia at age 21 and was later recommended treatment in the form of a long-acting injectable antipsychotic.

Category: Organized, evidence-based care
Key Audience: All clinicians
Tags: LAIs, LAMs, Long Acting Injectable Medications, Long-Acting Injectables, Long-Acting Medications
February 27, 2019 | Faq

Answers to commonly asked questions about long acting injectable antipsychotics.

Category: Organized, evidence-based care
Key Audience: All clinicians
Tags: LAIs, LAMs, Long Acting Injectable Medications, Long-Acting Injectables, Long-Acting Medications
February 27, 2019 | Clinical Guidelines

Dosing guidance for different types of long acting injectable antipsychotics.

Category: Organized, evidence-based care
Key Audience: All clinicians
Tags: LAIs, LAMs, Long Acting Injectable Medications, Long-Acting Injectables, Long-Acting Medications
February 25, 2019 | Clinical Guidelines

A detailed guide of how clozapine works for treatment. Part 1 of 4.

Category: Organized, evidence-based care
Key Audience: All clinicians
Tags: LAIs, LAMs, Long Acting Injectable Medications, Long-Acting Injectables, Long-Acting Medications
February 25, 2019 | Infographic

Learn why clinicians don't prescribe clozapine more often, how to educate patients on the medicine and how to carry out a clozapine trial.

Category: Organized, evidence-based care
Key Audience: All clinicians
Tags: LAIs, LAMs, Long Acting Injectable Medications, Long-Acting Injectables, Long-Acting Medications
February 25, 2019

A detailed guide of how clozapine works for treatment. Part 4 of 4.

Category: Organized, evidence-based care
Key Audience: All clinicians
Tags: LAIs, LAMs, Long Acting Injectable Medications, Long-Acting Injectables, Long-Acting Medications
February 25, 2019 | Clinical Guidelines

A detailed guide of how clozapine works for treatment. Part 3 of 4.

Category: Organized, evidence-based care
Key Audience: All clinicians
Tags: LAIs, LAMs, Long Acting Injectable Medications, Long-Acting Injectables, Long-Acting Medications
February 25, 2019 | Infographic

An overview of steps to take before starting clozapine and while it is being prescribed, as well as the timeline of side effects.

Category: Organized, evidence-based care
Key Audience: All clinicians
Tags: LAIs, LAMs, Long Acting Injectable Medications, Long-Acting Injectables, Long-Acting Medications
1 2 3
The Care Transitions Network is made possible by a grant made to the National Council for Behavioral Health by the Centers for Medicare and Medicaid Services, in a partnership between the National Council, Montefiore Medical Center, Northwell Health (formerly North Shore-LIJ Health System), the New York State Office of Mental Health and Netsmart Technologies. Contact us by emailing CareTransitions@TheNationalCouncil.org or calling 202-849-4920. The project described was supported by Funding Opportunity Number CMS-1L1-15-003 from the U.S. Department of Health & Human Services, Centers for Medicare & Medicaid Services. Disclaimer: The contents provided are solely the responsibility of the authors and do not necessarily represent the official views of HHS or any of its agencies.